- Home
- PROK vs HPAI Comparison
PROK vs HPAI Comparison
Compare PROK & HPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- HPAI
- Stock Information
- Founded
- PROK 2015
- HPAI 2023
- Country
- PROK United States
- HPAI Singapore
- Employees
- PROK N/A
- HPAI N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- HPAI
- Sector
- PROK Health Care
- HPAI
- Exchange
- PROK Nasdaq
- HPAI NYSE
- Market Cap
- PROK 186.8M
- HPAI 221.3M
- IPO Year
- PROK N/A
- HPAI N/A
- Fundamental
- Price
- PROK $1.05
- HPAI $6.65
- Analyst Decision
- PROK Buy
- HPAI
- Analyst Count
- PROK 5
- HPAI 0
- Target Price
- PROK $4.50
- HPAI N/A
- AVG Volume (30 Days)
- PROK 546.9K
- HPAI 5.6K
- Earning Date
- PROK 03-21-2025
- HPAI 03-18-2025
- Dividend Yield
- PROK N/A
- HPAI N/A
- EPS Growth
- PROK N/A
- HPAI N/A
- EPS
- PROK N/A
- HPAI N/A
- Revenue
- PROK N/A
- HPAI $29,575,625.00
- Revenue This Year
- PROK N/A
- HPAI N/A
- Revenue Next Year
- PROK N/A
- HPAI N/A
- P/E Ratio
- PROK N/A
- HPAI $33.41
- Revenue Growth
- PROK N/A
- HPAI 132.36
- 52 Week Low
- PROK $0.98
- HPAI $3.07
- 52 Week High
- PROK $4.44
- HPAI $14.74
- Technical
- Relative Strength Index (RSI)
- PROK 23.63
- HPAI N/A
- Support Level
- PROK $0.98
- HPAI N/A
- Resistance Level
- PROK $1.32
- HPAI N/A
- Average True Range (ATR)
- PROK 0.11
- HPAI 0.00
- MACD
- PROK -0.04
- HPAI 0.00
- Stochastic Oscillator
- PROK 10.61
- HPAI 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About HPAI HELPORT AI LTD
Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.